Alloreactive natural killer cells in targeting high-risk leukaemias

Annals of the Rheumatic Diseases

Volumn 67, Issue SUPPL. 3, 2008, Pages

  Moretta, L ^a,b   Locatelli, F ^c   Moretta, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNAM 1 RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND; LYMPHOCYTE RECEPTOR; NKP30 RECEPTOR; NKP46 RECEPTOR; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ALLOTYPE; CELL FUNCTION; CELL SPECIFICITY; CONFERENCE PAPER; CYTOKINE RELEASE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; IMMUNOREGULATION; INFLAMMATION; LEUKEMIA; LEUKEMIA CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN ALLOTYPES; KILLER CELLS, NATURAL; LEUKEMIA; RECEPTORS, KIR; RECEPTORS, NATURAL KILLER CELL;

EID: 56749178943     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.097980     Document Type: Conference Paper

References (69)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
2. Moretta L, Ciccone E, Mingari MC, Biassoni R, Moretta A. Human NK cells: origin, clonality, specificity and receptors. Adv Immunol 1994;55:341-80.
3. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
4. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002;2:957-65.
5. Parham P. Innate immunity: the unsung heroes. Nature 2003;423:20.
6. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, et al. Receptors for HLA-class I molecules in human natural killer cells. Annu Rev Immunol 1996;14:619-48.
7. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002;3:6-8.
8. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93.
9. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
10. Lopez-Botet M, Llano M, Navarro F, Bellon T. NK cell recognition of non-classical HLA class I molecules. Semin Immunol 2000;12:109-219.
11. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Biassoni R, et al. Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19:197-223.
12. Moretta A, Biassoni R, Bottino C, Mingari MC, Moretta L. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis. Immunol Today 2000;21:228-34.
13. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, et al. p46, a novel natural killer cell-specific surface molecule which mediates cell activation. J Exp Med 1997;186:1129- 36.
14. Passino A, Sivori, S, Bottino C, Malaspina A, Morelli L, Moretta L, et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998;188:953-60.
15. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999;190:1505-16.
16. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, et al. NKp44. a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-MHC restricted tumor cell lysis. J Exp Med 1998;187:2065-72.
17. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999;189:787-96.
18. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003;3:781-90.
19. Houchins JP, Yabe T, McSherry C, Bach FH. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med 1991;173:1017- 20.
20. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001;181:158-69.
21. Moretta A, Bottino C, Tripodi G, Vitale M, Pende D, Morelli L, et al. Novel surface molecules involved in human NK cell activation and triggering of the lytic machinery Int J Cancer Suppl 1992;7:6-10.
22. Valiante NM, Trinchien G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993;178:1397-406.
23. Sivori S, Parolini S, Falco M, Marcenaro E, Biassoni R, Bottino C, et al. 2B4 functions as a co-receptor in human natural killer cell activation. Eur J Immunol 2000;30:787-93.
24. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998;188:2083-90
25. Siliciano BF, Pratt JC, Schmidt RE, Ritz J, Reinherz EL. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 1985;317:428-30.
26. Arulanandam AR, Withka JM, Wyss DF, Wagner G, Kister A, Recny PP, et al. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC′C″ face of the human CD2 adhesion domain. Proc Natl Acad Sci USA 1993;90:11613-7.
27. Bottino C, Falco M, Parolini S, Marcenaro E, Augugliaro R, Sivori S, et al. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseases. J Exp Med 2001;194:235-46.
28. Falco M, Marcenaro E, Romeo E, Bellora F, Marras D, Moretta L, et al. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur J Immunol 2004;34:1663-72.
29. Vitale M, Falco M, Castriconi R, Parolini S, Zambello R, Semenzato G, et al. Identification of NKp80, a novel triggering molecule expressed by human natural killer cells. Eur J Immunol 2001;31:233-42.
30. Wefte S, Kuttruff S, Waldhauer I, Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol 2006;12:1334-42.
31. Marcenaro E, Augugliaro R, Falco M, Castriconi R, Parolini S, Sivori S, et al. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotocicity. Eur J Immunol 2003;33:3367-76.
32. Shibuya A, Campbell D, Hannum C, Yssel H, Franz-Bacon K, McClanahan T, et al. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996;4:573-81.
33. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-67.
34. Raymond N, Imbert A-M, Devilard E, Fabre S, Chabannon C, Xerri L, et al. DNAM-1 and PVR regulate of monocyte migration through endothelial junctions. J Exp Med 2004;199:1331-41.
35. Bonnet M. Biology and genetics of hybrid resistance. Adv Immunol 1987;41:333-445.
36. Moretta A, Tambussi G, Bottino C, Tripodi G, Merli A, Ciccone E, et al. A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med 1990;171:695-714.
37. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, et al. Identification of four subset of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 1990;172:1589-98.
38. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, et al. p58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 1993;178:597-604.
39. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati M, Vitale M, et al. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995;2:439-49.
40. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995;268:405-8.
41. Brown MG, Scalzo AA, Matsumoto K, Yokoyama WM. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol Rev 1997;155:53-65.
42. Smith HR, Idris AH, Yokoyama WM. Murine natural killer cell activation receptors. Immunol Rev 2001;181:115-25.
43. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001;19:291-330.
44. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 1994;180:537-44.
45. Vitale M, Sivori S, Pende D, Augugliaro R, Di Donato C, Amoroso A., et al. Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 1996;93:1453- 7.
46. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, Di Donato C, et al. The natural killer cell receptor specific for HLA.A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer. J Exp Med 1996;184:505-18.
47. Dohring C, Colonna M. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Eur J Immunol 1996;26:365-9.
48. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA.C molecules in human natural killer cells. J Exp Med 1995;182:875-84.
49. Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale, M, et al. The HLA.C specific "activatory" and " inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 1996;183:645-50.
50. Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, et al. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 1996;26:1816-24.
51. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, et al. Cytolytic T lymphocytes displaying natural killer (NK)-like activity. Expression of NK-related functional receptors fir HLA-class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol 1995;7:697-703.
52. Moretta L, Romagnani C, Pietra G, Moretta A, Mingari MC NK-CTL, a novel HLA-E-restricted T cell subset. Trends Immunol 2003;24:136- 43.
53. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 2004;4:190-8.
54. Ruggeri L, Capanni M, Urbani E, Perruccio K, Schlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-100.
55. Velardi A, Ruggeri L, Moretta A, Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 2002;23:438-44.
56. Sivori S, Cantoni C, Parolini S, Marcenaro E, Moretta L, Moretta A. IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur J Immunol 2003;33:3439-47.
57. Shilling HG, Young N, Guethlein LA, Cheng NW, Gardiner CM, Tyan D, et al. Genetic control of human NK cell repertoire. J Immunol 2002;169:239-47.
58. Shilling HG, McQueen KL, Cheng NW, Shizuru JA, Negrin RS, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood 2003;101:3730-40.
59. Ciccone E, Pende D, Viale O, Di Donato C, Orengo AM, Biassoni R, et al. Involvement of HLA class I alleles in NK cell specific function: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 1992;176:963-71.
60. Ciccone E, Pende D, Vitale M, Nanni L, Di Donato C, Bottino C, et al. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur J Immunol 1994;24:1003-6.
61. Costello RJ, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci M-J, Reviron D, et al. Defective expression and function of natural killer cell triggering receptors in patients with acute myeloid leukemia. Blood 2002;99:3661-7.
62. Bonnet D, Warren EH, Greenberg PD, Dick JE, Riddell SR. CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukaemia stem cells. Proc Natl Acad Sci USA 1999;96:8639-44.
63. Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukaemia. Nat Med 2000;6:1018-23.
64. Aversa F, Terenzi A, Tabilio A,Falzetti F, Carotti A, Ballanti S, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005;23:3447-54.
65. Pende D, Spaggiari GM, Marcenaro S, Martini S, Rivera P, Capobianco A, et al. Analysis of the receptor-ligand interactions in the NK-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias. Evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112). Blood 2005;105:2066-73.
66. Aversa F, Tabilio A, Terenzi A, Velardi A, Falzetti F, Giannoni C, et al. Successful engraftment of T-depleted haploidentical "three-loci" incompatible transplants in leukaemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994;84:3948-55.
67. Shlomchik WD, Couzens MS, Tang CB,McNiff J, Robert ME, Liu J, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412-5.
68. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A. The natural killer cell mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003;33:1657-66.
69. Asai O, Longo DL, Tian ZG, Hornung RL, Taub DD, Ruscetti, FW, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest 1998;101:1835-42.